Cancer treatment is better than ever before, thanks in part to more effective medications.
But these medications often carry high price tags and co-pays, causing financial stress for cancer patients and their families. Although some medications benefit patients substantially, others offer only moderate improvement, prompting questions about when the high costs are justified. Such questions lead to a discussion of value and how it can shape cancer care. They have also led to the creation and use of oncology value models, intended to help physicians, patients and policymakers determine whether a given cancer treatment’s cost aligns with its value.
So, what is a good value in terms of cancer treatment? Different people have different answers.
